Stocks in play: Appili Therapeutics Inc.
Announced its financial and operational results for the fiscal year ended March 31, 2022. The net loss and comprehensive loss of $25.1 million or $0.38 loss per share was $10.8 million higher than the net loss and comprehensive loss of $14.3 million or $0.24 loss per share during the year ended March 31, 2021. Appili Therapeutics Inc. shares T.APLI are trading unchanged at $0.07.
Read:
Innovative Food Stocks Responding to Conflict-, and Drought-Driven Food Supply Shocks
Crypto Miners Finding Success While Shifting Towards Environmentally Sustainable Operations
New Approaches Towards Immunotherapy Give Hope in Fight Against Solid Tumors
As a Major Social Media Shuffle Looms, Uptake and Value of Dogecoin (DOGE) Surges
New Regions Being Developed to Produce More Oil Amid Government’s Calls for More Output